Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Pill Causes Major Weight Loss in Eli Lilly Trial’s Results

The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year.

Gina Kolata
Author: Gina Kolata

Written by

Gina Kolata

in

Clinical Trials, Drugs (Pharmaceuticals), Eli Lilly and Company, GLP-1 RAs (Drug), Obesity, Research
←Cannonball with Wesley Morris: Beyoncé Isn’t Giving Up on America
The Trump-Backed Federal Budget Threatens Black Economic Progress. Here’s How Black Communities Can Reclaim Their Power→

More posts

  • Disney Offers $20M For Character.AI Assets As Startup Files For Chapter 11 Bankruptcy Protection

  • Trump has asked Kimberly Guilfoyle to resign, White House says

  • Controversial ‘Downstate’ Delays First Broadway Preview Due To Illness

  • Getting Booked: Here’s What 5 Models Read Backstage During the Spring 2027 Season

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube